Two of the world’s prominent healthcare-focused investment firms London-based GHO Capital Partners and Hong Kong-headquartered CBC Group have announced plans to join forces and establish what is set to become the largest pan-Asian healthcare investment platform. The move represents a significant consolidation of healthcare private equity expertise across Western and Asian markets.
GHO Capital, a specialist European healthcare private equity firm, and CBC Group, one of Asia’s leading healthcare-focused investment managers, are combining their capabilities to form a unified platform designed to deploy capital at scale across the Asian healthcare sector. The partnership will bring together the complementary strengths of both firms GHO Capital’s deep expertise in European healthcare investments and CBC Group’s extensive pan-Asian healthcare investment network and operational knowledge.
The combined entity is intended to serve as a go-to platform for institutional investors seeking meaningful exposure to the rapidly expanding healthcare markets across Asia, including high-growth economies in Southeast Asia, South Asia, and the broader Asia-Pacific region.
The new platform is positioned to be the largest of its kind focused on pan-Asian healthcare investment. Both firms have a strong track record of backing healthcare companies ranging from pharmaceutical businesses and medical technology providers to healthcare services companies and diagnostics platforms. By merging their resources, the two firms intend to accelerate deal flow and enhance portfolio support across their combined geographies.
CBC Group currently manages assets exceeding several billion dollars and has built a formidable presence in Asian healthcare markets through a series of landmark transactions. GHO Capital, on the other hand, brings with it an established reputation in European healthcare private equity with a portfolio spanning multiple sub-sectors of the healthcare industry.
For healthcare industry executives and operators across Asia, the formation of this pan-Asian healthcare investment platform signals growing institutional confidence in the region’s healthcare infrastructure and services sector. The scale of this partnership means larger tickets, longer investment horizons, and a wider operational support network for portfolio companies.
The alliance is structured to provide not just capital but also strategic guidance, governance frameworks, and global networks elements that are increasingly critical for healthcare businesses operating in complex, regulation-intensive Asian markets.
Both GHO Capital and CBC Group have cultivated strong relationships with global limited partners, including sovereign wealth funds, pension funds, and endowments. The combined platform is expected to attract fresh capital commitments from these institutional investors who are actively increasing allocations to healthcare as a defensive and high-growth asset class.
The formation of this healthcare private equity alliance also underlines the growing investor appetite for pan-Asian healthcare investment opportunities at a time when demographic shifts, rising chronic disease burden, and healthcare infrastructure gaps across Asia are creating compelling long-term investment cases.
The two firms have indicated that the new platform will operate with a collaborative leadership structure, drawing on senior talent from both organizations. While specific management appointments are yet to be publicly detailed, both firms have emphasized that the integration will preserve the investment discipline and sector focus that have defined their individual identities.
GHO Capital was founded with a vision of being a dedicated healthcare investor, and CBC Group has similarly built its entire platform around the healthcare sector. This alignment in sectoral focus is expected to make the integration operationally coherent and strategically cohesive.
The establishment of this platform sets a new benchmark for healthcare private equity in Asia. With a combined reach spanning Europe and Asia, the new entity is poised to participate in some of the most consequential healthcare investment transactions in the coming years. For healthcare businesses looking for a well-resourced, sector-specialist investor with global connectivity, this platform is expected to emerge as a preferred institutional partner.
The announcement has drawn attention from across the global healthcare investment community, and further details on the structure, fund size, and strategic priorities of the combined pan-Asian healthcare investment platform are anticipated in the months ahead.
